National Pharmaceutical Council CSO and Executive Vice President Robert Dubois is set to participate in a panel discussion at the upcoming MedCity CONVERGE conference.
The panel session, “Promising Drugs, Pricing and Access,” is set for 10:30-11:45 a.m. July 12.
Dubois will be speaking alongside Merck Associate Vice President Patrick Davish on how pharmaceutical companies can balance research, innovation and patient affordability.
To learn more about the panel, click here.
More information about MedCity CONVERGE can be found here.